News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Zold - Clinical - IND (World)
Allergy Therapeutics plc Release: FDA Confirms Clinical Hold Will be Lifted on all Three INDs for Pollinex Quattro Products 4/26/2011
Oxford BioMedica PLC (OXB.L) Announces US IND Approval for Novel Ocular Product in Stargardt Disease 3/21/2011
MorphoSys AG Reaches Clinical Milestone with Pfizer Inc. (PFE) 1/31/2011
APR Applied Pharma Research S.A. and Labtec GmbH Announce Filing for Approval in Europe of Zolmitriptan Oral Dispersible Film (ODF) 12/2/2010
Auris Medical AG Receives IND Approval from FDA to Start Clinical Trial With AM-101 11/24/2010
Oxford BioMedica PLC (OXB.L) Announces US IND Approval for Novel Ocular Product in Wet AMD 11/9/2010
Cytonet GmbH & Co. KG Release: FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the U.S. 8/10/2010
Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce Preliminary U.S. Registration Strategy for Investigational Drug, Hematide(TM)/Peginesatide, to Treat Anemia in Chronic Renal Failure 8/5/2010
ANTISENSE PHARMA GmbH Obtains IND for Clinical Studies in the USA 8/3/2010
HanAll BioPharma Co., Ltd. (009420.KS) Release: U.S. IND Accepted by the FDA in Support of the Clinical Development HL 007, a Unique Fixed Dose Combination to Treat Cardiovascular Disease 7/12/2010
Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States 7/8/2010
DBV Technologies Receives IND Clearance from FDA to Begin Clinical Trial in Peanut Allergy 7/6/2010
Can-Fite BioPharma Announces Opening of CF101 Dermatology IND with Phase 2/3 Psoriasis Protocol 6/7/2010
Lotus Pharmaceuticals, Inc.'s Innovative Drug to Receive SFDA Fast Track Approval 4/20/2010
Biolaxy Secures IND Approval for Oral Insulin 11/24/2009
Sol-Gel's IND Application for Rosacea Accepted by FDA 11/11/2009
Diamyd Medical AB: New Study Application to Vaccinate Against Juvenile Diabetes with Diamyd(R) 12/18/2008
APR Applied Pharma Research S.A. Receive IND Approval From FDA for a New NSAID Matrix Patch Product 11/17/2008
Mesoblast Limited Bone Marrow Transplant Trial Receives US FDA Clearance 11/5/2008
FDA Accepts Arana Therapeutics's Anti-inflammatory IND 11/3/2008
TaiGen Biotechnology Announces Presentation of Nemonoxacin at the Joint Meeting of ICAAC/IDSA 10/20/2008
Arana Therapeutics Updates Inflammatory Pipeline Milestones 9/22/2008
Pharming Group (PHGUF.PK) Release: FDA Authorizes Investigational New Drug Application for Recombinant Human C1 Inhibitor in Kidney Transplantation 9/3/2008